US Stock MarketDetailed Quotes

NAMS NewAmsterdam Pharma

Watchlist
  • 20.500
  • +0.290+1.43%
Close May 14 16:00 ET
  • 20.990
  • +0.490+2.39%
Post 18:14 ET
1.84BMarket Cap-7592P/E (TTM)

NewAmsterdam Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

NewAmsterdam Pharma Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

--

Revenue(YoY)

1.40M

-83.76%
EPS(YoY)

-1.06

-107.84%
Analyst Rating

Strong Buy

May 13, 2024

NewAmsterdam Pharma Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 7 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: EUR

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 2.107M--
--2024/Q2-- / 1.273M--
--2024/Q11.304M / 1.607M--
--2023/Q4-- / 1.767M--
--2023/Q2-- / 1.950M--
--2023/Q1-- / 1.467M--
--2022/Q4-- / 1.750M--
--2022/Q3-- / 3.500M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 2.107M--
--2024/Q2-- / 1.273M--
--2024/Q11.304M / 1.607M--
--2023/Q4-- / 1.767M--
--2023/Q2-- / 1.950M--
--2023/Q1-- / 1.467M--
--2022/Q4-- / 1.750M--
--2022/Q3-- / 3.500M--
--------
--------

Unlock Free Earnings Estimates

NewAmsterdam Pharma Earnings Reports

  • 10-Q: Quarterly report

    May 9 04:39

  • NewAmsterdam Pharma | 10-K: Annual report

    Feb 28 21:02

  • NewAmsterdam Pharma | 6-K: Report of foreign private issuer (related to financial reporting)

    Aug 7, 2023 19:24

  • NewAmsterdam Pharma | 6-K: Report of foreign private issuer (related to financial reporting)

    Jun 10, 2023 09:39

    • Read more

    Analysis

    Analyst Rating

    Updated: May 13, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg